Diagnostics
Faster, more accurate tests would help ensure that patients are receiving the best treatment for a variety of infectious diseases, guide more effective infection control practices and improve the tracking of outbreaks. It is also critical to ensure the capacity to rapidly develop diagnostic assays in the event of an emerging infectious disease. Better tests would also help protect our dwindling supply of effective antibiotics by better identifying resistance and reducing their misuse.
In recent years, policymakers have proposed changes in oversight of diagnostic testing. IDSA has consistently provided feedback to make sure that policy changes do not result in diminished access to timely, accurate ID testing and diagnosis.
The latest
Loading...
Protecting patient access to ID diagnostics
Amanda Jezek, IDSA’s senior VP of public policy & government relations, sat down with Angela Caliendo, MD, PhD, FIDSA, to discuss the importance of laboratory-developed tests in ID patient care and how proposed legislation will hinder the development and use of these tests.
Contact your congressional representative through our Advocacy Center to show your support for the development of new and rapid diagnostic tests for infectious diseases.